Response to the letter “Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU and infusional 5-FU alone in advanced pancreatic carcinoma patients”, by C. Allior (Ann. Oncol 2004; 15: 1576–1577)
| Autor: | Ducreux, M., Mitry, E., Ould-Kaci, M., Boige, V., Seitz, J.F., Bugat, R., Breau, J.L., Bouché, O., Etienne, P.L., Tigaud, J.M., Morvan, F., Cvitkovic, E., Rougier, P. |
|---|---|
| Zdroj: | In Annals of Oncology October 2004 15(10):1577-1578 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|